Pilocarpine Ophthalmic Topical Cream, Dose 3: Clinical Trials

2 trials of Pilocarpine Ophthalmic Topical Cream, Dose 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Pilocarpine Ophthalmic Topical Cream, Dose 3: new trials by email Literature Review of Pilocarpine Ophthalmic Topical Cream, Dose 3 trials Research Report on Pilocarpine Ophthalmic Topical Cream, Dose 3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine Ophthalmic Topical Cream, Dose 2, Pilocarpine Ophthalmic Topical Cream, Dose 3 - Dry Eye Disease, Kerato Conjunctivitis Sicca
Phase 2CompletedGlaukos Corporation2262022-01-032023-07-12
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine Ophthalmic Topical Cream, Dose 2, Pilocarpine Ophthalmic Topical Cream, Dose 3 - Presbyopia
Phase 2CompletedGlaukos Corporation1232022-01-032023-09-01

Conditions studied

Corneal Diseases (1)  ·  Dry Eye Syndromes (1)  ·  Eye Diseases (1)  ·  Keratoconjunctivitis (1)  ·  Presbyopia (1)  ·  Refractive Errors (1)

Sponsors

Glaukos Corporation (2)

Countries

United States (2)